🇺🇸 FDA
Patent

US 12090183

Methods of treating solid or lymphatic tumors by combination therapy

granted A61KA61K35/761A61K39/3955

Quick answer

US patent 12090183 (Methods of treating solid or lymphatic tumors by combination therapy) held by CG ONCOLOGY, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CG ONCOLOGY, INC.
Grant date
Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/761, A61K39/3955, A61P, A61P35/02